ovarian hyperstimulation sign
Conditions
Interventions
experimental group:The treatment of Ren meridian moxibustion was carried out on the basis of the control group. Once every 3 days.
control group:Hydroxyethyl starch sodium chloride injection was given intravenously once a day, and human albumin was supplemented with 20 g per day according to serum albumin, and electrolytes were s
Sponsors
Shenzhen Maternity and Child Healthcare Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1)Moderate OHSS meets Western diagnostic criteria (according to the Clinical Guidelines for the Prevention and Treatment of Moderate to Severe OHSS published by the Practice Committee of the American Society for Reproductive Medicine in 2016). Clinical manifestations: abdominal symptoms (including bloating nausea mild nausea and vomiting); enlarged ovaries and presence of ascites confirmed by ultrasound. Laboratory parameters: erythrocyte pressure volume >41% leukocytes >15 × 106/mL. (2) meteorism (spleen-kidney yang deficiency syndrome) Chinese medicine diagnostic criteria refer to the "Chinese Medicine and Gynecology" clinical manifestations of abdominal distension nausea and vomiting ascites face white swelling of the limbs difficulty in micturition cold limbs and fear of cold. The tongue is pale the moss is white and slippery and the pulse is thin. The tongue and pulse are used as diagnostic references. (3) Patients developed OHSS after oocyte retrieval or embryo transfer. (4) The patients were compliant gave informed consent to the study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Hydroxyethyl starch sodium chloride injection allergy human albumin injection allergy. (2) Patients with concomitant cholestasis syndrome deep venous thrombosis or arterial suspension thrombosis benign intracranial hypertension syndrome multiple cerebral infarcts (due to cerebral vascular embolism in a hypercoagulable state) pseudocholinesterase deficiency etc.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| PCV;VEGF;IL-6;Cr;E2;Hospitalization expense;D-Dimer; | — |
Primary
| Measure | Time frame |
|---|---|
| Maximum diameter of the ovary; | — |
Countries
China
Contacts
Public ContactShening Zhu
Shenzhen Maternity and Child Healthcare Hospital
Outcome results
None listed